Zidovudine is the generic name for the antiretroviral drug AZT [1]. AZT was the first drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV/AIDS [2].
What is AZT used for?
AZT is used to treat HIV infection in adults and children [3]. It is typically part of a combination therapy regimen, meaning it is taken with other antiretroviral medications [3]. This combination approach helps to suppress the virus, prevent the progression to AIDS, and reduce the risk of transmitting HIV to others [3].
When did Zidovudine (AZT) patents expire?
The original patents for zidovudine have long since expired. The drug was first approved in the United States in 1987 [2]. Patent protection typically lasts for a set number of years, after which generic versions of the drug can be manufactured and sold [4]. Information on the specific patent expiry dates for zidovudine can be found on resources like DrugPatentWatch.com [4].
What are the common side effects of Zidovudine?
Common side effects associated with zidovudine use can include nausea, vomiting, diarrhea, headache, fatigue, muscle pain, and changes in sleep patterns [3]. More serious side effects, though less common, can include bone marrow suppression leading to anemia and neutropenia, lactic acidosis, and myopathy [3]. Patients are advised to report any persistent or bothersome side effects to their healthcare provider [3].
Can generic versions of Zidovudine be accessed?
Yes, generic versions of zidovudine are available. Following the expiration of its patents, other pharmaceutical companies have been able to produce and market generic zidovudine [4]. This often leads to lower treatment costs compared to the brand-name drug [4].
How does Zidovudine work?
Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) [1]. It works by interfering with the HIV virus's ability to replicate by blocking an enzyme called reverse transcriptase [1]. This enzyme is essential for the virus to convert its RNA into DNA, a step necessary for it to infect and multiply within human cells [1].
What is the difference between Zidovudine and other HIV medications?
Zidovudine is one of many antiretroviral drugs used to treat HIV, belonging to the NRTI class [1][3]. Other classes of HIV medications include non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), and entry inhibitors, each working through different mechanisms to combat the virus [3]. The specific combination of drugs prescribed is tailored to the individual patient's needs, viral load, CD4 count, and potential resistance [3].
Are there any new developments or alternatives to Zidovudine?
While zidovudine remains an important component in HIV treatment regimens, research and development in HIV therapy continue to advance [3]. Newer antiretroviral drugs and combination therapies with improved efficacy, tolerability, and dosing schedules are available [3]. Treatment decisions are made in consultation with healthcare professionals who consider the latest clinical guidelines and patient-specific factors [3].
---
Sources
1. https://www.drugpatentwatch.com/drugs/zidovudine
2. https://www.fda.gov/ (Note: Specific FDA approval dates for drugs can be found via their website search function or historical databases.)
3. https://www.hiv.gov/
4. https://www.drugpatentwatch.com/